Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-throughput genotyping assay approaches.

P Y Kwok1

  • 1Washington University School of Medicine, St Louis, MO 63110, USA. kwok@genetics.wustl.edu

Pharmacogenomics
|March 22, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beta-adrenergic receptor polymorphisms and cardiac graft function in potential organ donors.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Genotyping by ligation assays.

Current protocols in human genetics·2008
Same author

Heat-inducible translationally controlled tumor protein of Trichinella pseudospiralis: cloning and regulation of gene expression.

Parasitology research·2006
Same author

Extract signal out of noise.

Human genomics·2005
Same author

SNP genotyping and molecular haplotyping of DNA pools.

Cold Spring Harbor symposia on quantitative biology·2004
Same author

Genomics. Genetic association by whole-genome analysis?

Science (New York, N.Y.)·2001
Same journal

Adherence to international pharmacogenomic recommendations in pediatric cancer care: a cohort analysis embedded within the MARVEL-PIC randomized trial.

Pharmacogenomics·2026
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
See all related articles

High-throughput genotyping methods are advancing for pharmacogenomics, utilizing allele-specific mechanisms for single nucleotide polymorphism (SNP) analysis. Engineering solutions are crucial for implementing these robust genotyping technologies in routine applications.

Area of Science:

  • Biotechnology
  • Genomics
  • Pharmacogenomics

Background:

  • Pharmacogenomics requires high-throughput genotyping for analyzing numerous individuals and single nucleotide polymorphism (SNP) markers.
  • Existing non-gel-based genotyping methods rely on four primary allelic discrimination mechanisms.

Purpose of the Study:

  • To review the mechanisms and formats for high-throughput genotyping.
  • To highlight the need for engineering solutions to enable routine application of these technologies.

Main Methods:

  • Allele-specific hybridization
  • Allele-specific primer extension
  • Allele-specific oligonucleotide ligation
  • Allele-specific cleavage of flap probes
  • Homogeneous and solid-phase reaction formats

Related Experiment Videos

  • Detection methods: fluorescence intensity, polarization, mass spectrometry

    • Main Results:

    • Multiple viable high-throughput genotyping methods have been developed by combining discrimination mechanisms, reaction formats, and detection techniques.
    • The biochemical foundations for robust genotyping are established.

    Conclusions:

    • The development of high-throughput genotyping technologies is progressing rapidly.
    • Engineering solutions are essential to translate these advancements into routine pharmacogenomic applications.